Given that lymph node metastasis is a well-established predictor of adverse prognosis in PTC, these findings underscore the clinical relevance of CXCR7 and TAGLN2 and suggest their potential utility as prognostic biomarkers. The gene discussed is TAGLN2; the disease is metastatic malignant neoplasm in the lymph nodes.